Medical AI Alliance
← Company Index
Healthcare InfrastructureKOSDAQ 204840158 approvals51 trials

GL Pharm Tech Corp.

Official website

Founded and listed on KOSDAQ in 2014, GL Pharm Tech is an improved-new-drug pharmaceutical R&D company.

As of 2026-10-10, GL Pharm Tech Corp. has 158 Korean MFDS drug approvals, 5 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Products & technology

  • Cavalin CRNeuropathic pain treatment
  • Acnon Cream, Palens EC tablets, Clearatin Ibu Double Spot TalcOTC and prescription drugs
  • Dinax, famotidine tablets (GL Pharma)Anti-inflammatory and anti-ulcer drugs
  • Alsaxen (GL Pharma)OTC drug for rheumatoid arthritis and osteoarthritis

Regulatory approvals

data.go.kr

158 Korean MFDS drug approvals · 1965–2026

  • MFDS drugRecodew eye drops 5%(Recoflavone monohydrate)2026-09-08
    Drug · Prescription · Approval202602688
  • MFDS drugPitael OD Tab. 4mg2026-07-27
    Drug · Prescription · Approval202602165
  • MFDS drugPitael OD Tab. 2mg2026-07-27
    Drug · Prescription · Approval202602166
  • MFDS drugTelmieltan Tab. 80/5mg2026-07-21
    Drug · Prescription · Approval202602094
  • MFDS drugTelmieltan Tab. 80/2.5mg2026-07-21
    Drug · Prescription · Approval202602095
  • MFDS drugTelmieltan Tab. 40/5mg2026-07-21
    Drug · Prescription · Approval202602096
  • MFDS drugTelmieltan Tab. 40/2.5mg2026-07-21
    Drug · Prescription · Approval202602097
  • MFDS drugRovaelzet OD Tab. 10/5mg2026-06-22
    Drug · Prescription · Approval202601760
  • MFDS drugRovaelzet OD Tab. 10/20mg2026-06-22
    Drug · Prescription · Approval202601761
  • MFDS drugRovaelzet OD Tab. 10/10mg2026-06-22
    Drug · Prescription · Approval202601762
  • MFDS drugPro-Enza soft cap.2026-04-20
    Drug · Prescription · Approval202601123
  • MFDS drugLyriel OD Tab. 150mg(Pregabalin)2026-02-12
    Drug · Prescription · Approval202600401
Show 68 more
  • MFDS drugLyriel OD Tab. 75mg(Pregabalin)2026-02-12
    Drug · Prescription · Approval202600402
  • MFDS drugLyriel OD Tab. 50mg(Pregabalin)2026-02-12
    Drug · Prescription · Approval202600403
  • MFDS drugGINKOL Tab.240mg (Ginkgo Leaf Dried Ext.)2024-11-26
    Drug · OTC · Notification202402773
  • MFDS drugDoubleLax Enteric Coating Tab.2024-11-22
    Drug · OTC · Notification202402763
  • MFDS drugGL almagate Tab. 500mg2024-08-29
    Drug · OTC · Notification202402085
  • MFDS drugCrarexinS Tab.2024-07-30
    Drug · OTC · Notification202401836
  • MFDS drugPlan GE tab.2024-06-19
    Drug · OTC · Notification202401477
  • MFDS drugAsprazol Cap. 100/5mg(Aspirin, Rabeprazole)2024-05-31
    Drug · Prescription · Approval202401369
  • MFDS drugKabalin CR Tab. 75mg(pregabalin)2024-05-07
    Drug · Prescription · Approval202401115
  • MFDS drugTeraEl tab. 5mg2024-02-29
    Drug · Prescription · Approval202400436
  • MFDS drugSexon season active Tab.2023-03-07
    Drug · OTC · Approval202300780
  • MFDS drugSexon season low active Tab.2023-03-07
    Drug · OTC · Approval202300781
  • MFDS drugSexon season Tab.2023-03-07
    Drug · OTC · Approval202300782
  • MFDS drugForsiel tab. 5mg2023-01-25
    Drug · Prescription · Approval202300336
  • MFDS drugGL-Estradiol Valerate Tab.Revoked2023-01-13
    Drug · Prescription · Notification202300247
  • MFDS drugDapa-glip tab. 10/100mg2022-12-16
    Drug · Prescription · Approval202204513
  • MFDS drugSepiderm GN Cream2022-09-23
    Drug · OTC · Notification202203646
  • MFDS drugGL Dienogest Tab. 2mg2022-08-30
    Drug · Prescription · Approval202203436
  • MFDS drugTeneliel Duo SR Tab. 20/1000mg2022-07-01
    Drug · Prescription · Approval202202719
  • MFDS drugTeneliel Duo SR Tab. 10/750mg2022-07-01
    Drug · Prescription · Approval202202720
  • MFDS drugTeneliel Duo SR Tab. 10/500mg2022-07-01
    Drug · Prescription · Approval202202721
  • MFDS drugElla-5days tab.(Ulipristal Acetate)2022-06-13
    Drug · Prescription · Approval202202456
  • MFDS drugGL SitaMet XR tab. 50/500mg2022-05-09
    Drug · Prescription · Approval202201876
  • MFDS drugGL SitaMet XR tab. 50/1000mg2022-05-09
    Drug · Prescription · Approval202201877
  • MFDS drugGL SitaMet XR tab. 100/1000mg2022-05-09
    Drug · Prescription · Approval202201878
  • MFDS drugPlan-A Tab.2022-05-02
    Drug · Prescription · Approval202201765
  • MFDS drugGLSUGAMMADEX Inj. (SUGAMMADEX SODIUM)2022-03-21
    Drug · Prescription · Approval202201125
  • MFDS drugForsiel tab. 10mg2022-03-15
    Drug · Prescription · Approval202201075
  • MFDS drugEl-Tragen tab(linagiltin)Revoked2022-01-06
    Drug · Prescription · Approval202200101
  • MFDS drugEsomedin plus tab. 20/800mg2021-11-10
    Drug · Prescription · Approval202107383
  • MFDS drugGLTranexamic Acid Tab. 500mg2021-10-20
    Drug · Prescription · Approval202107030
  • MFDS drugElcoxia Tab. 30mg (Etoricoxib)Revoked2021-10-19
    Drug · Prescription · Approval202106996
  • MFDS drugFamocomp Tab.2021-08-18
    Drug · OTC · Notification202105999
  • MFDS drugDinacs Tab. 50mg (Diclofenac Sodium)2021-08-18
    Drug · Prescription · Approval202106009
  • MFDS drugJardiel Tab. 10mgRevoked2021-08-17
    Drug · Prescription · Approval202105978
  • MFDS drugJardiel Tab. 25mgRevoked2021-08-17
    Drug · Prescription · Approval202105979
  • MFDS drugPitastan Tab. 4mg2021-04-30
    Drug · Prescription · Approval202103533
  • MFDS drugPitastan Tab. 1mg2021-04-05
    Drug · Prescription · Approval202102918
  • MFDS drugTeneliel Tab. 20mg2021-04-01
    Drug · Prescription · Approval202102862
  • MFDS drugAtoLzet Tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101585
  • MFDS drugAtoLzet Tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101586
  • MFDS drugAtoLzet Tab. 10/40mg2021-02-18
    Drug · Prescription · Approval202101587
  • MFDS drugSubsidiary: 지엘파마㈜GL Melatonin PR tab. 2mgRevoked2021-02-08
    Drug · Prescription · Approval202101189
  • MFDS drugHathorii Tab.2021-02-05
    Drug · OTC · Notification202101152
  • MFDS drugGL levonorgestrel 0.03mgRevoked2021-01-21
    Drug · OTC · Approval202100636
  • MFDS drugXeltoz tab. 5mgRevoked2020-12-23
    Drug · Prescription · Approval202009148
  • MFDS drugSexcon plus Tab.Revoked2020-11-23
    Drug · OTC · Approval202008127
  • MFDS drugGL esogestrel tab. 0.075mgRevoked2020-10-30
    Drug · OTC · Approval202007452
  • MFDS drugGL Ibutok cream 5%(Ibuprofen piconol)2020-10-16
    Drug · Prescription · Notification202007099
  • MFDS drugFinastone 1mg tab.(finasterid)2020-09-24
    Drug · Prescription · Approval202006597
  • MFDS drugIen Q Plus Tab.Revoked2020-06-16
    Drug · OTC · Notification202004414
  • MFDS drugMagpherol Plus Soft Cap.2020-05-29
    Drug · OTC · Notification202004088
  • MFDS drugGL Famotidine Tab. 10mg2020-05-06
    Drug · OTC · Notification202003288
  • MFDS drugPitastan Tab. 2mg2020-04-29
    Drug · Prescription · Approval202003208
  • MFDS drugElsin Capsule(Erdosteine)2020-04-14
    Drug · OTC · Notification202002625
  • MFDS drugAlpina Tab.Revoked2020-03-19
    Drug · OTC · Notification202001927
  • MFDS drugParence Enteric Coated Tab.2020-02-14
    Drug · Prescription · Notification202001013
  • MFDS drugHaisomin S Cap.2020-01-15
    Drug · OTC · Notification202000239
  • MFDS drugHokurol Patch 1mgRevoked2019-12-26
    Drug · Prescription · Approval201908657
  • MFDS drugHokurol Patch 2mgRevoked2019-12-26
    Drug · Prescription · Approval201908658
  • MFDS drugHokurol Patch 0.5mgRevoked2019-12-26
    Drug · Prescription · Approval201908659
  • MFDS drugTiblin Tab. 2.5mg2019-12-03
    Drug · Prescription · Approval201908215
  • MFDS drugEsomedin Tab. 40mg2019-10-25
    Drug · Prescription · Approval201907454
  • MFDS drugEsomedin Tab. 20mg2019-10-25
    Drug · Prescription · Approval201907455
  • MFDS drugLevotidine Tab.Revoked2019-10-10
    Drug · Prescription · Notification201907155
  • MFDS drugEpinasin TabRevoked2019-09-02
    Drug · Prescription · Approval201906235
  • MFDS drugEltis F Tab.Revoked2019-08-21
    Drug · Prescription · Notification201905921
  • MFDS drugGL Ofloxacin Tab. 100mg2019-07-10
    Drug · Prescription · Approval201904655

Showing the 80 most recent of 158 records.

Clinical trials

data.go.kr

51 MFDS clinical trial authorisations · 2012–2026 (Phase 1 28 · Bioequivalence 20 · Phase 3 3)

  • Phase 3W25052026-08-20

    16 trial sites

  • BioequivalenceW26032026-07-01

    2 trial sites

  • BioequivalenceW25042025-12-18

    2 trial sites

  • Phase 1W25022025-11-07

    1 trial site

  • Phase 1W24012025-11-06

    2 trial sites

  • Phase 1W24102025-09-01

    1 trial site

  • BioequivalenceW25012025-06-05

    1 trial site

  • BioequivalenceW24052025-04-18

    1 trial site

  • Phase 1W24012025-02-12

    2 trial sites

  • BioequivalenceGLN2DY2025-02-07

    1 trial site

  • Phase 1W24062024-11-29

    1 trial site

  • Phase 1W24012024-09-19

    2 trial sites

Show 39 more
  • Phase 1W24012024-08-23

    2 trial sites

  • Bioequivalence파렌스장용정2024-03-11

    1 trial site

  • Bioequivalence파렌스장용정2024-03-11

    1 trial site

  • BioequivalenceGLL6TE(가칭)정2023-07-21

    1 trial site

  • Phase 1GLM1RA2023-06-16

    1 trial site

  • Bioequivalence쎄스콘원정2023-05-24

    1 trial site

  • Phase 1GLM1RA2023-05-22

    1 trial site

  • BioequivalenceGLL5LE정2023-04-20

    1 trial site

  • Phase 1GLM1RA2023-02-24

    1 trial site

  • BioequivalenceGLK12DI정2021-07-12

    2 trial sites

  • Phase 1GLK2DS정(가칭)2021-03-22

    1 trial site

  • BioequivalencePMK1EL2021-03-15

    2 trial sites

  • BioequivalencePMJ5DE정(가칭)2020-08-31

    2 trial sites

  • Phase 1GLH8NDE2019-07-23

    1 trial site

  • BioequivalenceGLI1AE정(가칭)2019-06-03

    2 trial sites

  • Phase 1GLA5PR GLARS-NF3정 75mg, 150mg2018-12-14

    4 trial sites

  • BioequivalenceCWI4TI정 (가칭)2018-11-27

    2 trial sites

  • Phase 1GLH1SM 서방정2018-11-23

    1 trial site

  • Phase 1GLH1SM 서방정2018-11-22

    1 trial site

  • Bioequivalence크라운메페남산캡슐250mg2016-09-28
  • Phase 1GL2702 GLARS 정2016-04-29

    1 trial site

  • Phase 1GLA5PR2016-04-07

    1 trial site

  • Phase 1GLA5PR2016-04-07

    1 trial site

  • Phase 1GL29072015-09-04

    1 trial site

  • Bioequivalence크라운심바스타틴정40밀리그램(가칭)2015-08-28
  • Phase 1GLE1RCW정2015-06-29

    1 trial site

  • Bioequivalence크라운아세클로페낙정100밀리그램2015-04-21
  • Bioequivalence크라운시메티딘정400밀리그램2015-04-15
  • Phase 3GLE3PA2015-02-27

    1 trial site

  • Bioequivalence크라운라니티딘염산염정2014-07-09

    2 trial sites

  • Phase 1GLA5PR2014-05-13

    1 trial site

  • Phase 3GL2702 GLARS 정2013-11-14

    1 trial site

  • Phase 1GLA5PR2013-09-30

    1 trial site

  • Phase 1GL2702 GLARS 정2013-06-19

    1 trial site

  • Phase 1GL29072013-01-08

    1 trial site

  • Phase 1GL2702 GLARS 정2012-07-18

    1 trial site

  • Phase 1GLA5PR2012-07-04

    1 trial site

  • Phase 1GLA5PR2012-07-03

    1 trial site

  • Phase 1GL29072012-01-13

    1 trial site

Global clinical trials

ClinicalTrials.gov · sponsor-matched
Show 6 more trials

R&D and key agreements

Source: DART corporate disclosure

GLM1RA · 라베프라졸·아스피린 복합제 · 기술이전(로열티 수취) · Licensed out to domestic/overseas pharma companies for royalty

GLL6TE · 테라조신 · 기술이전(로열티 수취) · Licensed out to domestic/overseas pharma companies for royalty

GLH8NDE · 안구건조증 · 임상3상 완료 · In-licensed from Dong-A ST in Nov 2017; Eupatiline-derivative new substance

지소렌정 · 위염(천연물) · 사업화 완료 · Patented improved extraction method; manufactured by Poongrim Muyak

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 31 more patents

AI reads

MAA server logs · IP-verified
104
Times AI engines pulled GL Pharm Tech Corp.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

4
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

100
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

27
live 1
Last 7 days
85
live 4
Last 30 days
104
live 4
All time
  • OpenAIChatGPT-Userlive4
  • OpenAIOAI-SearchBot71
  • GoogleGoogleOther16
  • MicrosoftBingbot8
  • PerplexityPerplexityBot3
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for GL Pharm Tech Corp. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryHealthcare Infrastructure

CJ CHEILJEDANG CORP.100

CJ CheilJedang, founded and KOSPI-listed in 2007, operates food, BIO, and logistics businesses as a CJ Group intermediate holding company.

Kwangdong Healthbio Co., Ltd.100

Supplies red ginseng, probiotics, and other health functional foods to 300+ clients via OEM/ODM.

Cellromax Science Co., Ltd.100

Founded in 2014 and listed on KOSDAQ in 2024, Cellromax Science is a health functional food company built on a nationwide pharmacy network.

KolmarBNH Co., Ltd100

Founded and listed on KOSDAQ in 2014, KolmarBNH develops health functional food and cosmetics materials and provides ODM/OEM manufacturing.

HEM Pharma Inc.70

KOSDAQ-listed microbiome healthcare company using the PMAS gut-microbiome simulation platform and the PeachBiome028 probiotic strain.

Carelabs Co.,Ltd70

Carelabs, founded in 2012 and KOSDAQ-listed in 2018, operates mobile healthcare and beauty care platforms.

DreamCIS INC.62

Contract research organization providing clinical trial, post-marketing surveillance, and site management services to pharma and medtech clients.

S&D Co., Ltd60

Founded in 1998 and listed on KOSDAQ in 2021, S&D is a functional food ingredient company.

CosLeaguer Global Co., Ltd.60

Founded in 1991 and listed on KOSDAQ in 2002, CosLeaguer Global distributes botulinum toxin and fillers and manufactures cosmetics.

Icure Pharmaceutical Incorporation60

Founded in 2000 and listed on KOSDAQ in 2018, Icure Pharmaceutical develops TDDS drug patches and cosmetics OEM/ODM.

Bioten Co., Ltd60

Develops water-solubilized curcumin complexes for enhanced bioavailability using its WIN-T technology.

COSMAX BTI, INC.56

Founded in 1992 and listed on KOSPI in 2006, COSMAX BTI is the COSMAX Group holding company overseeing health food and cosmetics affiliates.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition